Northern Trust’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-210,891
Closed -$122K 4526
2024
Q3
$122K Sell
210,891
-519,988
-71% -$291K ﹤0.01% 4007
2024
Q2
$452K Sell
730,879
-23,584
-3% -$19.9K ﹤0.01% 3541
2024
Q1
$1.94M Buy
754,463
+22,541
+3% +$55.1K ﹤0.01% 2981
2023
Q4
$1.49M Buy
731,922
+8,798
+1% +$16.1K ﹤0.01% 3139
2023
Q3
$1.24M Buy
723,124
+12,625
+2% +$22.4K ﹤0.01% 3200
2023
Q2
$1.39M Buy
710,499
+557,939
+366% +$1.31M ﹤0.01% 3219
2023
Q1
$424K Buy
152,560
+3,890
+3% +$11.1K ﹤0.01% 3534
2022
Q4
$513K Buy
148,670
+25,350
+21% +$72.4K ﹤0.01% 3498
2022
Q3
$317K Buy
123,320
+8,040
+7% +$25.6K ﹤0.01% 3666
2022
Q2
$279K Sell
115,280
-281,067
-71% -$738K ﹤0.01% 3756
2022
Q1
$1.63M Sell
396,347
-12,559
-3% -$66.5K ﹤0.01% 3190
2021
Q4
$5.26M Buy
408,906
+39,503
+11% +$437K ﹤0.01% 2647
2021
Q3
$3.99M Sell
369,403
-135,032
-27% -$1.23M ﹤0.01% 2873
2021
Q2
$4.61M Buy
504,435
+221,789
+78% +$2.05M ﹤0.01% 2890
2021
Q1
$2.67M Sell
282,646
-16,307
-5% -$225K ﹤0.01% 3096
2020
Q4
$1.18M Sell
298,953
-18,360
-6% -$55.5K ﹤0.01% 3454
2020
Q3
$841K Sell
317,313
-21,190
-6% -$78.7K ﹤0.01% 3461
2020
Q2
$2.25M Buy
338,503
+48,650
+17% +$328K ﹤0.01% 2978
2020
Q1
$1.69M Buy
289,853
+10,262
+4% +$86.2K ﹤0.01% 2952
2019
Q4
$2.51M Buy
279,591
+9,427
+3% +$78.6K ﹤0.01% 2988
2019
Q3
$2.33M Buy
270,164
+154,769
+134% +$1.56M ﹤0.01% 3016
2019
Q2
$1.29M Buy
115,395
+37,119
+47% +$425K ﹤0.01% 3273
2019
Q1
$1.04M Buy
78,276
+169
+0.2% +$2.26K ﹤0.01% 3344
2018
Q4
$1.21M Buy
+78,107
New +$1.49M ﹤0.01% 3302

Other funds holding GRTS

Northern Trust's GRTS Position: Q4 2024 in Review

Northern Trust sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 210,891 shares — an estimated $122K sold.

Northern Trust first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $5.26M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Northern Trust reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Northern Trust sold 210,891 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $122K.
  • Northern Trust first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Northern Trust's Gritstone bio, Inc. Common Stock position peaked at $5.26M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.